Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Journal of Pharmacy Practice|January 24, 2016
Docetaxel/Cyclophosphamide-Induced Phototherapy RecallSteven P Ludlow, Sarah S ChehabMelanoma Research|September 13, 2013
Cumulative dermatologic toxicity with ipilimumab and vemurafenib responsive to corticosteroidsSteven P Ludlow, Yanina PasikhovaJournal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2015
Delayed dermatologic hypersensitivity reaction secondary to ipilimumabSteven P Ludlow, Noriko KayInternational Journal of Clinical Pharmacy|January 25, 2014
Fluconazole associated agranulocytosis and thrombocytopeniaYanina Pasikhova, Steven P LudlowMelanoma Research|March 17, 2016
New-onset toxicity with programmed death-1 inhibitor rechallengeSteven P Ludlow, Stephanie Andrews, Yanina Pasikhova, et al.Melanoma Research|February 2, 2017
Checkpoint inhibitor-associated drug reaction with eosinophilia and systemic symptom syndromeSayeef Mirza, Ebone' Hill, Steven P Ludlow, et al.JAAPA : Official Journal of the American Academy of Physician Assistants|May 27, 2025
Multisystem immune-related adverse reactions with immune checkpoint inhibitorsAmy Jayson, Maria Tsambarlis, Hardik Thakkar, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 3, 2023
Safety outcomes of pembrolizumab with platinum agent chemotherapy combined with 5-fluorouracil or taxane derivative in head and neck cancerBenjamin Lee, Sarah S Chehab, Wenyi Fan, et al.Pageof 1